Evidence map›Paper›PMID 40577240›Full record

ArticleBrain : a journal of neurology2025

Extreme exercise in males is linked to mTOR signalling and onset of amyotrophic lateral sclerosis.

David O'Brien, Elham Alhathli, Ceryl Harwood, Debarati Bhattacharya, Kriti Gupta, Thomas Julian, Marcel Weinreich, Ryan J H West, Dennis Wang, Ross P Byrne and 5 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

David O'BrienSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.
Elham AlhathliSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.
Ceryl HarwoodBarnsley Hospitals NHS Foundation Trust and Barnsley Metropolitan Borough Council, Barnsley S75 2EP, UK.
Debarati BhattacharyaSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.
Kriti GuptaSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.
Thomas JulianManchester Centre for Genomic Medicine, Manchester University, Manchester M13 9WL, UK.
Marcel WeinreichDepartment of Clinical Neurobiology at the German Cancer Research Center (DKFZ), Heidelberg University, Heidelberg 69120, Germany.
Ryan J H WestSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.ORCID 0000-0001-9873-2258
Dennis WangNational Heart and Lung Institute, Imperial College London, London SW3 6LY, UK.ORCID 0000-0003-0068-1005
Ross P ByrneComplex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin D02 PN40, Ireland.
Russell L McLaughlinComplex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin D02 PN40, Ireland.ORCID 0000-0003-3915-2135
Joanne WuuALS Center and the Department of Neurology, University of Miami, Miami, FL 33136, USA.ORCID 0009-0005-9643-9855
Michael BenatarALS Center and the Department of Neurology, University of Miami, Miami, FL 33136, USA.ORCID 0000-0003-4241-5135
Johnathan Cooper-KnockSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.ORCID 0000-0002-0873-8689
Pamela J ShawSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.ORCID 0000-0002-8925-2567

Funding

ALS Association 23-PP-664Milken InstituteMND Association 894-791My Name'5 Doddie Foundation DOD/14/43NIHR NF-SI-0617-10077NIHR Sheffield Biomedical Research Centre NIHR 203321NIHR Sheffield Clinical Research Facility 879-791NIHR Sheffield Clinical Research Facility 979-799Tambourine's ALS Breakthrough Research FundTargetALS
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is thought to be caused by interaction between genetic and environmental factors leading to motor neuron (MN) degeneration. Physical exercise has been linked to ALS but controversy remains. A key question is to determine which individuals might be at risk of exercise-associated ALS, because unnecessary avoidance of exercise could be harmful. We implemented complementary strategies including Mendelian randomization (MR) and multiple questionnaire-based measures of physical exercise in different cohorts. We include a prospective study involving UK Biobank participants where we could test for a relationship between exercise and the timing of future ALS symptom onset. To interrogate the molecular basis of our observations we performed a genetic association study of 'extreme' exercise, equivalent to >6 h of strenuous exercise or >12 h of any leisure-time exercise per week. Our data suggest that the link between increased physical exercise and ALS is particularly important for males who perform the most activity; with no evidence of a link in females. We determined that extreme exercise in males is associated with loss-of-function genetic variants within a number of mammalian target of rapamycin (mTOR) signalling genes that are also differentially expressed in ALS spinal cord. Activity-induced mTOR signalling has been shown to selectively benefit MN. Therefore, our findings could imply that moderate exercise is neuroprotective via enhanced mTOR signalling, but extreme exercise in men is associated with neurotoxicity and ALS via a failure of this mechanism. There was no significant overlap between genes associated with extreme exercise and those associated with ALS risk, consistent with a true gene-environment interaction rather than a shared genetic basis. We are not yet able to make individual-level recommendations regarding exercise and risk of ALS, but our conclusions should provide focus for future investigation.

Indexed as

Amyotrophic Lateral SclerosisExerciseSignal TransductionTOR Serine-Threonine KinasesAgedCohort StudiesFemaleHumansMaleMendelian Randomization AnalysisMiddle AgedProspective StudiesMTOR protein, humanTOR Serine-Threonine Kinasesamyotrophic lateral sclerosis (ALS)exercisegene–environment interactionmammalian target of rapamycin (mTOR) signalling

Identifiers

PMID40577240
PMCPMC12493055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.